Won Saudi SFDA Authoritative Certification, Ruipu Medical Adds Another Heavyweight Milestone to Its Internationalization Strategy
From Product to System: Passing the Strict Review of Saudi SFDA
Pulmonary hypertension and respiratory failure are major challenges in the treatment of critical illnesses. With years of technological accumulation in the field of inhaled nitric oxide therapy, Ruipu Medical successfully passed the evaluation of the Saudi Food and Drug Authority (SFDA). This authorization not only covers the main unit system, but also includes a full set of consumables such as disposable corrugated tubes, neonatal/adult connectors, and disposable split-flow mixers in the scope of approval, achieving coverage of clinical scenarios for patients of all ages, from adults to neonates. This marks that Ruipu has established a complete solution capability from "core equipment" to "supporting accessories," laying a solid product foundation for entering the high-end respiratory support market.
Saudi SFDA Certification: An Access Credential for the Middle East's High-End Medical Market
As one of the largest and most stringent medical device markets in the Middle East, Saudi Arabia's SFDA certification is regarded as an important threshold for entering the region. Obtaining this authorization means that Ruipu's products can be legally sold and used in hospitals and medical institutions within Saudi Arabia, providing a compliance basis for subsequent participation in local tenders and clinical procurement.


Compliance Capability: A Reflection of Corporate Responsibility
Amid the trend of continuously strengthening medical device regulation globally, whether a company can meet the regulatory requirements of different countries is directly related to its sustainable development. The MDMA authorization obtained by Ruipu this time strictly complies with the provisions of the Saudi Royal Decree "Medical Devices Law," covering the full-process requirements from product design and clinical
evaluation to post-market management. Ruipu always insists on internalizing compliance as a daily operational standard, thereby winning the trust of users and partners.
Continuous Improvement: Every Certification Is a New Starting Point
Obtaining the Saudi SFDA authorization is not the end, but the starting point for further expanding into international markets. Ruipu will continue to track regulatory developments in various countries, continuously improve its quality management system, and ensure product safety and quality in an institutionalized and systematic manner.
Rooted Locally, Facing the World
Ruipu Medical will continue to take compliance as its cornerstone and products as its core, joining hands with global partners to provide reliable and effective solutions for the field of respiratory and critical care treatment.
APK Technology, a national high-tech enterprise with over 20 years of professional technologies and experience in providing OEM/0DM services for world-leading monitoring and ECG brands, delivering high-quality solutions for the global healthcare industry.
Exhibition Preview | ESICM LIVES 2026
Exhibition Preview | Salmed Connect 2026